INTRODUCTION
Schizophrenia is a chronic, recurrent disease that usually starts with a first psychotic episode and continues with periods of remission and acute psychosis.
While treatment response is achieved for up to 90% of persons with the first-episode psychosis (FEP) by the end of the first years of treatment, due to treatment nonadherence, the majority of patients relapse within a few years (Emsley 2013) . Thus, over its course, schizophrenia still remains a disorder with low functional recovery rates (Jaaskelainen et al. 2013 , Wunderink et al. 2013 and it is associated with poor quality of life in patients and their families (Wittchen et al. 2011) .
While the pathogenesis of schizophrenia is still largely unknown, a large body of genetic studies concluded that schizophrenia results from the gene x environment interaction (or epigenetic effects on the genome) (van Os & Kapur 2009). This once again revitalized the stress diathesis model of schizophrenia. This model implies that interaction of genes and environmental influences, including a variety of biological/chemical factors (infections, diseases), psychological stressors (mother-infant relationship, family dynamics, life events, childhood trauma) and social factors (society, migration) shape the vulnerability to schizophrenia (Bale et Stress response implies the activation of the hypothalamus-pituitary-adrenal (HPA) axis, which is activated by the release of corticotropin-releasing hormone (CRH) and of vasopressin (AVP), synthesized in the hypothalamus, which activate the secretion of adrenocorticotropic hormone (ACTH) from the pituitary, which finally stimulates secretion of cortisol from the adrenal gland. Cortisol subsequently initiates cascade effects in a number of systems (immune, neuroendocrine, inflammatory response, etc.), Alterations of stress response are thus reflected in the alterations of the HPA axis, and can be measured by the cortisol response, including cortisol and ACTH levels, non-suppression of cortisol secretion by dexamethasone in the dexamethasone suppression test, and in the dexamethasone/CRH test (Walker 2016) .
A significant number of findings in patients with first psychotic episode of schizophrenia could be related to alterations of stress response. These include altered HPA axis functions , Cullen et al. 2014 , increased baseline prolactin (Kahn et al. 2008 ), alterations in immune system (Miller et al. 2011 ), genetic expression of inflammatory markers (Gardiner et al. 2013) exp "Schizophrenia Spectrum and Other Psychotic Disorders"/ 6.
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Several systematic reviews attempted recently to summarize the current knowledge about the stress response impact in the development of first psychotic episode. The main findings of the reviews point out a possible alteration of the stress response, reflected by alterations of cortisole and ACTH blood levels in response to stress or pituitary volume (Aiello et al. 2012 ). However, in the majority of reviews, conflicting findings were reported as well , Ciufolini et al. 2014 , Girshkin et al. 2014 .
The aim of this study was to conduct an overview of all those systematic reviews in order to ascertain the role of the vulnerability to stress in the development of first psychotic episode, to provide recommendations for practice and to identify knowledge gaps that will guide further research.
METHODS

Study protocol
A protocol for this overview of systematic reviews was developed a priori and registered in the PROSPERO International Prospective Register of Systematic Reviews (No. CRD42016042155).
Literature search
The search was performed to find relevant studies from the five databases, including Cochrane Database of Systematic Reviews (CDSR), Database of Reviews of Effects (DARE), Embase, MEDLINE and PsychINFO. Each database was searched from its inception to February 9, 2017 . A complex search strategy was crea-ted encompassing search terms related to hydrocortisone, cortisol, stress and stress response, combined with key words for schizophrenia spectrum and other psychotic disorders. Search strategy was created for MEDLINE first (Table 1) and then adapted for other databases. The search was restricted to peer-reviewed journals and English language. Search strategy was very wide on purpose, in order to include all systematic reviews on association between stress, levels of cortisol and psychotic disorders.
Eligibility criteria
Types of studies
We included systematic reviews of any type of primary studies. Systematic reviews that were done by one author only or were using only one database for article search, were discarded as they do not meet the requirements of systematic review.
Participants and outcomes
We included systematic reviews that assessed impact of stress in the development of FEP in schizophrenia spectrum disorders according to the criteria of ICD-10 or DSM-IV or DSM-5.
Study selection
One author (LP) conducted the searches; two authors independently (LRG and AG) screened all retrieved bibliographic records against the inclusion criteria.
Potentially eligible systematic reviews were analyzed in full text by two authors (LRG and AG) independently. A third (LP) and the fourth author (MRK) were consulted in cases of disagreement.
Data extraction and management
A data collection form was developed and tested prior to starting the review. Two authors (LRG and AG) extracted the data independently and compared results afterwards. Disagreements were resolved by a third author (LP). Data extracted included review details (author, title and publication year), review aims, inclusion/exclusion criteria, date of last search and main findings about the impact of stress in development of the first psychotic episode. Authors of the included reviews were not contacted for further information. Data were presented narratively and in tabular form. For systematic reviews that included patients with more than one disease, only data regarding schizophrenia patients were reported. Articles with one author and only one database searched were excluded due to lack of systematic reviewing norms.
Quality assessment of included systematic reviews
Two authors (LRG and AG) independently assessed the methodological quality of the included systematic reviews using the AMSTAR checklist (Shea 2007) . Disagreements regarding AMSTAR score were resolved by discussion or a decision made by a third author (LP). 
RESULTS
Literature search
Initial database searching yielded 834 bibliographic records. After deletion of duplicates and screening of titles and abstracts, 35 full texts were analyzed, of which eight met all the inclusion criteria ( Table 2 ). The study selection process is presented in Figure 1 .
Characteristics of included systematic reviews
All included systematic reviews were published recently, between 2012 and 2016, and the main characteristics of each included systematic reviews are summarized in Table 3 . Inclusion criteria were slightly different among the selected systematic reviews: some explicitly indicated that included patients suffered from first-episode psychosis (Borges et . Even though our primary idea was to identify adult-based studies, one systematic review also included studies with patients above 15 years of age (Chaumette et al. 2015) . Only two systematic reviews did not specify their exclusion criteria (Aiello et al. 2012 , Fond et al. 2015 , while others had similar exclusion criteria, including studies with already published samples, physical illness, naturalistic stressors, metabolically demanding tasks, studies with imaging tasks, or with reactivity to stress, urinary cortisol measures, comments, abstracts and reviews. Half of the included systematic reviews had also performed a meta-analysis (Berger et Table 3 .
Main findings of included systematic reviews
Aiello et al. analyzed stress abnormalities in individuals at risk of psychosis. They reported that relatives of patients with schizophrenia had increased ACTH blood levels in response to stress and increased pituitary volume, whereas from three studies on cortisol level after stress exposure in relatives only one found increased cortisol levels. Studies on pituitary volume showed that HPA axis hyperactivity is already present before the onset of psychosis in patients with ultra-high risk for psychosis (UHR-P) compared to controls (ultrahigh risk who did not convert to psychosis, UHR-NP). Studies on hippocampus showed that some authors noticed a hippocampal volume increase in participants who made the transition to psychosis, despite the increased activity in the same participants. This review concluded that enhanced response of HPA axis to stress may be part of biological vulnerability to psychosis, which is present already before the psychosis onset (Aiello et al. 2012 ).
Berger et al. investigated cortisol awakening response (CAR) among the patients along the psychosis continuum including schizophrenia, first-episode psychosis, and atrisk metal states (ARMS) compared to healthy controls. Flattened CAR was found in patients with schizophrenia and first-time psychosis, but not in those at-risk. The authors conclude that CAR may be important marker for transition risk, but warn about methodological problems in included studies, such as small number of studies, small sample sizes and different scales being used for scoring symptom severity (Berger et al. 2016 ).
Borges et al. reported that 6 primary studies on cortisol levels found higher plasma cortisol levels when comparing patients with FEP with healthy controls, while 4 studies showed no significant difference. Studies on pituitary volume showed that 4 studies reported a larger pituitary volume comparing FEP with healthy controls, while 5 studies showed no significant difference. Additionally, 2 studies showed that longer duration of psychosis was associated with a reduction in pituitary volume, while 3 studies showed that prolactinenhanced antipsychotics were associated with larger pituitary volume. They concluded that patients with FEP exhibit specific pattern of HPA axis hyperactivity, as evidenced by higher baseline cortisol levels compared to controls, blunted cortisol awakening response and enlarged pituitary on MRI scan ).
Chaumette et al. showed no significant difference in cortisol levels in the first French cohort of young helpseekers (ICAAR, Influence du Cannabis sur l'émer-gence de symptômes psychopathologiques des Adolescents et jeunes Adultes présentant un état mental à Risque) or when comparing FEP with control group. Studies on cortisol levels in UHR showed slightly higher salivary cortisol level at baseline than healthy controls. Their meta-analysis revealed a significantly higher salivary basal cortisol levels in UHR compared to controls, but none between FEP and controls or UHR and FEP. They warn that their results indicate that basal levels of cortisol may not be used as a reliable biomarker of early psychosis (Chaumette et al. 2015) .
Ciufolini et al. included three studies with individuals with schizophrenia and used meta-analysis to investigate HPA axis response to social stress. The results showed that subjects with schizophrenia have lower cortisol levels in preparation and during the tasks of the stress response tests (Ciufolini et al. 2014) .
Fond et al. showed that multiple studies reported a basal hyperactivity of the HPA axis in male patients with FEP and that it may be correlated with disease severity. Also, it was found that antipsychotics can normalize diurnal cortisol hypersecretion, but they did not blunt cortisol awakening response in FEP (Fond et al. 2015) . Table 4 . AMSTAR score on methodological quality of the included systematic reviews AMSTAR domains Study, year Girshkin et al. conducted a meta-analysis that showed a slight increase in morning cortisol levels in schizophrenia when compared to healthy controls, but with significant heterogeneity among studies. Subgroup analyses revealed bigger effect sizes in schizophrenia when compared to FEP, but neither age nor sex were found to be significant confounders. However, bigger increase in morning cortisol level was observed in those sampled before 8 am, and medication status was also found to be significantly associated with morning cortisol levels in people with schizophrenia (Girshkin et al. 2014 ).
Lange et al. analyzed emotional and endocrinological response to experimentally induced psychosocial stress in patients with schizophrenia spectrum disorder (SSD). They reported that first-onset medication naïve SSD patients may show differences in subjective responses to stress measures and cortisol release, Psychiatria Danubina, 2017; Vol. 29, No. 1, pp 14-23 unlike chronically ill SSD patients, which could be a correlate of pathophysiological dysfunction of the HPA axis prior or at the onset of SSD (Lange et al. 2016 ).
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Quality assessment of included systematic reviews
AMSTAR score on the methodological quality of each included systematic reviews is shown in Table 4 . Overall, the methodological quality of included systematic reviews was inadequate, with 4 reviews of low quality, 3 reviews of medium quality and 1 review of high quality. Only one of the reviews reported having a priori defined protocol, which was registered in PROSPERO (Lange et al. 2016 ). The majority of the reviews did not report a list of both included and excluded studies or analyze quality of included studies ( Table 4) .
Conflict of interest in included systematic reviews
None of the 8 systematic reviews was funded by forprofit industry; all of them were funded by various nonprofit governmental and non-governmental organizations. Authors of 6 systematic reviews reported having no conflict of interest (Aiello et 
DISCUSSION
The current overview included 8 systematic reviews about the role of stress in the onset of schizophrenia published between 2012 and 2016, of overall inadequate methodological quality.
The main findings of the reviews point out a possible alteration of the stress response, in a subgroup of persons with psychosis proneness. This is observable even before the onset of psychosis in persons at risk suggested by: (i) increased ACTH blood levels in response to stress and increased pituitary volume in relatives of patients with schizophrenia (Aiello et al. 2012) , and (ii) a significantly higher salivary basal cortisol levels in patients with ultra-high risk for psychosis compared to controls (Chaumette et al. 2015) . Compared to controls, in persons in whom transition to psychosis occurs, increased hippocampal volume (Aiello et al. 2012 ), higher plasma cortisol levels ) larger pituitary volume , as well as a basal hyperactivity of the HPA axis (in males only) (Fond et al. 2015) was found. However, in the majority of reviews, conflicting findings were reported as well , Ciufolini et al. 2014 , Girshkin et al. 2014 ), or authors reported no differences between FEP and controls ). One review found that patients along the psychosis-continuum have a blunted CAR compared to healthy controls, and further subgroup analyzis revealed that this difference is only present in patients with FEP and schizophrenia but not in individuals at high risk for psychosis (Berger et al. 2016 ). Together with meta-analysis of cortisol levels in patients with schizophrenia that showed elevated morning cortisol compared to controls (Girshkin et al. 2014 ) and altered HPA-axis response to psychosocial stress that was characterized by lower anticipation and peak cortisol levels (Ciufolini et al. 2014 ), this represents strong evidence for dysregulated HPA-axis activity in patients with schizophrenia, characterized by a flat diurnal cortisol curve with overall high cortisol levels, and alterations in HPA-axis reactivity to laboratory-induced psychosocial stress. Another review showed that showed that first-episode, medication naive patients with SSD experience e more anxiety and less control during the task than healthy controls and seem to be more disposed to a subjective responses to stress reaction compared to chronically ill patients (Lange et al. 2016 ).
Some of the observed inconsistencies may be explained with other factors, primarily relating to the methodology of the studies included in the reviews. These include the lack of standardisation of biological assessment methods of stress response (e.g. blood cortisol, salivary cortisol, hippocampal volume, etc.), different or no psychological assessments of stress response, the lack of assessment of treatment methods (Vives et al. 2015) , as well as the lack of standardisation of outcomes (e.g. several psychiatric rating scales, different cut-offs and follow-up periods).
Other factors may include the effects of illnessrelated factors such as the duration and severity of the symptoms, or the influence of medication on stress response. This may explain a significant heterogeneity of the studies included in some of the reviews. In particular, longer duration of psychosis was associated with a reduction in pituitary volume , the severity of illness was found to be correlated with the hyperactivity of HPA axis (Fond et al. 2015) and higher basal cortisol levels were found in patients with schizophrenia compared to patients with FEP or controls (Fond et al. 2015) . Somatic comorbidities (e.g. chronic illnesses such as diabetes) which may influence stress response as well, were not assessed in the reviews (Wosu et al. 2013 ).
Lastly, antipsychotic medication, other psychoactive substances, as well as other forms of treatment that may mediate stress response were not systematically assessed in the reviews. For example, prolactin-enhanced antipsychotics were associated with larger pituitary volume ). Anti-inflammatory drugs, which are available over the counter and easily accessible to controls and patients may possibly influence stress response as well (Di Luigi et al. 2007 ). The use of cannabis, which is quite common among persons with FEP (Marconi et al. 2016) , may affect the levels of salivary cortisol (King et al. 2011 , Monteleone et al. 2014 . Lastly, treatment with psychotherapies and meditation-like techniques that may alter stress response were not assessed in those studies as well (Jensen et al. 2015 , Rosenkranz et al. 2016 ).
Limitations
The following limitations of this overview were noted: (i) Methodological quality of included systematic reviews was not high. Future systematic reviews should follow relevant checklist for methodological quality to improve quality of evidence from secondary research.
(ii) In general, no information on participants that may be relevant for overall stress response were included in the review. These include somatic comorbidities of the patients, the use of anti-inflammatory medication, the use of psychiatric medication, the use of marijuana, the use of alternative or additional treatment, like mediation, yoga, psychotherapy. (iii) Clinically relevant outcomes were not analyzed. First, reviews failed to analyze the association of alterations of biological stress biomarkers (i.e. cortisol) with clinically meaningful findings such as overall vulnerability to stress using scales of stressful events, or scales of daily hassles, stress response to provoking stimuli. Secondly, reviews did not analyze clinical outcomes of longitudinal studies that assess stress response in different state of the FEP (at risk, acute psychosis, remission of symptoms, functional remission) and different state of treatment (i.e., psychotherapy, medications such as antipsychotics).
Clinical implications
The aim of this review was to ascertain whether alterations of stress response found in persons at risk for schizophrenia and FEP may serve as a marker that may predict psychotic episodes and serve as a biological marker of treatment response, and serve as a treatment tool in clinical practice.
However, given the heterogeneity of current results, there is no solid evidence for uniform alterations of stress response found in persons with FEP that may serve as a marker of vulnerability to stress and possibly proneness to psychotic state in response to daily hassles.
Implications for future research
Given the initial aims of the review, as well as the current limitations of this overview, future systematic reviews should (i) include systematic reviews that follow relevant checklist for methodological quality to improve quality of evidence from secondary research.
(ii) Include studies that analyzed the influence of stress on psychosis with more than one biological marker of stress response (i.e. awakening plasma cortisol, awakening salivary cortisol, cortisol in response to stress stimuli) which could improve reliability of the studies. (iii) All systematic reviews should take into account the effects of potential factors in the studies that may influence stress response (e.g. marijuana use, drugs, chronic illnesses, etc.). (iv) Include studies that analyze clinical outcomes such as overall vulnerability to stress using scales of stressful events, or scales of daily hassles, stress response to provoking stimuli over a longitudinal period encompassing a different state of the FEP (at risk, acute psychosis, remission of symptoms, functional remission) and different state of treatment (i.e., psychotherapy, medications such as antipsychotics).
